Cancer Screening

Multigene germline genetic testing should be considered for all patients with advanced cancer to better guide treatment selection, according to study results published in Journal of Clinical Oncology.

Late-stage breast cancer diagnoses were more common following shutdowns during the COVID-19 pandemic, according to research presented at ASCO 2021.

Breast cancer and cervical cancer screenings declined sharply during the early part of the COVID-19 pandemic, according to CDC data released today.

Researchers validated a liver cancer risk test algorithm for identifying patients with chronic hepatitis C at low risk for hepatocellular carcinoma, according to a study presented at The Digital International Liver Congress.

A blood-based test demonstrated efficacy and high specificity in detecting multiple cancer types with diverse biological features, paving the way for a new screening option, according to research published in Annals of Oncology.

Black veterans had a higher prevalence of advanced colorectal neoplasia and colorectal cancer compared with white veterans, according to research published in the Journal of Clinical Gastroenterology.

The COVID-19 pandemic disrupted colorectal cancer screening programs around the world.

Of the known racial disparities in cancer incidence and mortality, the disproportionate burden of prostate cancer among Black men remains one of the most pronounced.

The U.S. Preventive Services Task Force issued updated recommendations for colorectal cancer screening in JAMA.

Patients with five or more comorbidities were less likely to receive screening for colorectal cancer, according to research published in the Journal of Osteopathic Medicine.